120 related articles for article (PubMed ID: 1538283)
1. Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood.
Finberg RW; Newburger JW; Mikati MA; Heller AH; Burns JC
J Pediatr; 1992 Mar; 120(3):376-80. PubMed ID: 1538283
[TBL] [Abstract][Full Text] [Related]
2. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
Front Immunol; 2021; 12():660506. PubMed ID: 34093549
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion.
Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
J Reprod Immunol; 1996 Aug; 31(1-2):125-41. PubMed ID: 8887127
[TBL] [Abstract][Full Text] [Related]
4. The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy.
Bohn AB; Nederby L; Harbo T; Skovbo A; Vorup-Jensen T; Krog J; Jakobsen J; Hokland ME
Eur J Neurol; 2011 Jun; 18(6):919-24. PubMed ID: 21219545
[TBL] [Abstract][Full Text] [Related]
5. [Antibody-dependent cell-mediated cytotoxicity (K-cell population) of peripheral lymphocytes in Kawasaki disease and allergic conditions. 1. Relation between K-cell population and the blood immune complex content in Kawasaki disease].
Suzuki M
Arerugi; 1983 Mar; 32(3):164-72. PubMed ID: 6625894
[No Abstract] [Full Text] [Related]
6. Effect of intravenous immune globulin on natural killer cell activity: possible association with autoimmune neutropenia and idiopathic thrombocytopenia.
Engelhard D; Waner JL; Kapoor N; Good RA
J Pediatr; 1986 Jan; 108(1):77-81. PubMed ID: 3080573
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
Lee KY; Lee HS; Hong JH; Han JW; Lee JS; Whang KT
J Trop Pediatr; 2005 Apr; 51(2):98-101. PubMed ID: 15677370
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome.
Klassen TP; Rowe PC; Gafni A
J Pediatr; 1993 Apr; 122(4):538-42. PubMed ID: 8463897
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease.
Lee HK; Kim DS; Noh GW; Lee KY
Yonsei Med J; 1996 Oct; 37(5):357-63. PubMed ID: 8997168
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G.
Roussev RG; Ng SC; Coulam CB
Am J Reprod Immunol; 2007 Apr; 57(4):262-9. PubMed ID: 17362387
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
13. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
Weisman LE; Anthony BF; Hemming VG; Fischer GW
J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
[TBL] [Abstract][Full Text] [Related]
14. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
Lo MS; Newburger JW
Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
[TBL] [Abstract][Full Text] [Related]
15. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
[TBL] [Abstract][Full Text] [Related]
17. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
Burns JC; Touma R; Song Y; Padilla RL; Tremoulet AH; Sidney J; Sette A; Franco A
Autoimmunity; 2015 May; 48(3):181-8. PubMed ID: 25822882
[TBL] [Abstract][Full Text] [Related]
18. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).
Lin CY; Hwang B
Ann Allergy; 1987 Oct; 59(4):291-7. PubMed ID: 3662131
[TBL] [Abstract][Full Text] [Related]
19. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy.
Leucht S; Uttenreuther-Fischer MM; Gaedicke G; Fischer P
Clin Immunol; 2001 Apr; 99(1):18-29. PubMed ID: 11286538
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
Tsujimoto H; Takeshita S; Nakatani K; Kawamura Y; Tokutomi T; Sekine I
Clin Immunol; 2002 May; 103(2):161-8. PubMed ID: 12027421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
